Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling

Oncology Reports

Volumn 32, Issue 5, 2014, Pages 2070-2076

  Chen, Puxiang ^a   Zeng, Mengjun ^a   Zhao, Yan ^a   Fang, Xiaolin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cofilin; LIM kinase 1; Metastasis; MiR 138; Ovarian cancer; Talen technology

Indexed keywords

COFILIN; CYCLINE; LIM KINASE 1; MICRORNA; MICRORNA 138; UNCLASSIFIED DRUG; ACTIN DEPOLYMERIZING FACTOR; LIM KINASE; LIMK1 PROTEIN, HUMAN; MIRN138 MICRORNA, HUMAN;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; OVARY CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UPREGULATION; WESTERN BLOTTING; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM; METASTASIS; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ACTIN DEPOLYMERIZING FACTORS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HUMANS; LIM KINASES; MICRORNAS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84907287148     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3461     Document Type: Article

References (23)

1. Kigawa J: New strategy for overcoming resistance to chemotherapy of ovarian cancer. Yonago Acta Med 56: 43-50, 2013.
2. Miles GD, Seiler M, Rodriguez L, Rajagopal G and Bhanot G: Identifying microRNA/mRNA dysregulations in ovarian cancer. BMC Res Notes 5: 164, 2012.
3. Ozols RF: Treatment goals in ovarian cancer. Int J Gynecol Cancer 15 (Suppl 1): 3-11, 2005.
4. Davila M, Frost AR, Grizzle WE and Chakrabarti R: LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 278: 36868-36875, 2003.
5. Zhou Y, Su J, Shi L, Liao Q and Su Q: DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Oncol Rep 29: 605-612, 2013.
6. Nishimura Y, Yoshioka K, Bernard O, Bereczky B and Itoh K: A role of LIM kinase 1/cofilin pathway in regulating endocytic trafficking of EGF receptor in human breast cancer cells. Histochem Cell Biol 126: 627-638, 2006.
7. Chen Q, Jiao D, Hu H, et al: Downregulation of LIMK1 level inhibits migration of lung cancer cells and enhances sensitivity to chemotherapy drugs. Oncol Res 20: 491-498, 2013.
8. Jang I, Jeon BT, Jeong EA, et al: Pak1/LIMK1/Cofilin pathway contributes to tumor migration and invasion in human non-small sell lung sarcinomas and sell lines. Korean J Physiol Pharmacol 16: 159-165, 2012.
9. Zhang W, Gan N and Zhou J: Immunohistochemical investigation of the correlation between LIM kinase 1 expression and development and progression of human ovarian carcinoma. J Int Med Res 40: 1067-1073, 2012.
10. Lin H, Dai T, Xiong H, et al: Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PloS one 5: e15797, 2010.
11. Zhang H, Zhang H, Zhao M, et al: MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer. Cell Physiol Biochem 31: 56-65, 2013.
12. Jin Y, Chen D, Cabay RJ, Wang A, Crowe DL and Zhou X: Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma. Int Rev Cell Mol Biol 303: 357-385, 2013.
13. Liu X, Jiang L, Wang A, Yu J, Shi F and Zhou X: MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 286: 217-222, 2009.
14. Liu X, Wang C, Chen Z, et al: MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Biochem J 440: 23-31, 2011.
15. Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT: MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis 33: 1113-1120, 2012.
16. Gong H, Song L, Lin C, et al: Downregulation of miR-138 sustains NF-kappaB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Clin Cancer Res 19: 1083-1093, 2013.
17. Long L, Huang G, Zhu H, Guo Y, Liu Y and Huo J: Downregulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. J Transl Med 11: 275, 2013.
18. Wang Q, Tang H, Yin S and Dong C: Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9. Oncol Rep 29: 2046-2052, 2013.
19. Yeh YM, Chuang CM, Chao KC and Wang LH: MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1alpha. Int J Cancer 133: 867-878, 2013.
20. Wan L, Zhang L, Fan K and Wang J: miR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cells. Mol Cell Biochem 390: 85-91, 2014.
21. Zhang HS, Zhao JW, Wang H, et al: LIM kinase 1 is required for insulin.dependent cell growth of osteosarcoma cell lines. Mol Med Rep 9: 103-108, 2014.
22. Manetti F: Recent findings confirm LIM domain kinases as emerging target candidates for cancer therapy. Curr Cancer Drug Targets 12: 543-560, 2012.
23. Golubovskaya VM, Sumbler B, Ho B, Yemma M and Cance WG: MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells. Anticancer Agents Med Chem 14: 18-28, 2014.